Max Healthcare Institute Ltd

Net profit of Max Healthcare Institute rose 74.34% to Rs 491.30 crore in the quarter ended September 2025 as against Rs 281.81 crore during the previous quarter ended September 2024. Sales rose 25.07% to Rs 2135.47 crore in the quarter ended September 2025 as against Rs 1707.46 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales2135.471707.46 25 OPM %26.9326.39 - PBDT554.13457.84 21 PBT446.03373.69 19 NP491.30281.81 74 Powered by Capital Market - Live

The growth in revenue was driven by an increase in OBDs. International patient revenue stood at Rs 231 crore, reflecting a growth of 25% YoY, and accounted for nearly 9% of the hospital revenue. Bed occupancy for the quarter was at 77%, with occupied bed days (OBDs) up by 19% YoY. ARPOB for Q2 FY26 stood at Rs 77.3 thousand compared to Rs 76.2 thousand in Q2 FY25 and Rs 78.0 thousand in Q1 FY26. Network operating EBITDA in Q2 FY26 was Rs 694 crore, reflecting a growth of 23% YoY. EBITDA margin for the Network stood at 26.9% compared to 26.6% in Q2 FY25 and 24.9% in Q1 FY26. EBITDA margin for existing units was 27.5%. Overall EBITDA per bed in Q2 FY26 stood at Rs 73.4 lakhs compared to Rs 71.2 lakhs in Q2 FY25 and Rs 68.5 lakhs in Q1 FY26. EBITDA per bed for existing units stood at Rs 76.5 lakhs, up 7% YoY. Max Lab (non-captive pathology vertical) reported revenue of Rs 54 crore during the quarter, recording a growth of 16% YoY. Max Lab services now has presence across 60-plus cities and it offers a comprehensive range of over 2,700 tests. Max@Home gross revenue in Q2 FY26 was Rs 63 crore, reflecting a growth of 20% YoY, driven by physio & rehab, critical care (assistance services), medicine delivery (transactional services) and medical rooms. The company recorded a favourable tax impact of Rs 149 crore, arising from the merger of Crosslay Remedies (CRL) and Jaypee Healthcare (JHL). Excluding this one-time impact, PAT during the quarter stood at Rs 406 crore, up 16% YoY. Free cash from operations was Rs 291 crore versus Rs 464 crore in Q2 FY25 and Rs 389 crore in Q1 FY26. An amount of Rs 456 crore was deployed towards ongoing expansion plans and upgradation of facilities at newer units. In addition, Rs 146 crore was distributed as dividend. Net debt at the end of the quarter stood at Rs 2,067 crore compared to Rs 1,755 crore at the end of June 2025. Pursuant to the binding term sheet executed in July 2025, JHL, a wholly owned subsidiary (WoS) of the company, has divested its hospitals located in Village Chitta and Anoopshahr, District Bulandshahr effective 18 September 2025. The NCLT Chandigarh Bench approved scheme of amalgamation of JHL and CRL, both wholly owned subsidiaries of the company, with an appointed date of 05 October 2024. The 160 bed brownfield tower, including the additional radiation oncology program, has been commissioned at MSSH Mohali. The 268 bed brownfield tower at Nanavati-Max, Mumbai, is to be commissioned next week. Abhay Soi, chairman and managing director, Max Healthcare Institute, said: We continued our strong performance this quarter with revenue and operating EBITDA growth of 21% and 23%, respectively. Integration of newly acquired Max Super Speciality Hospital, Noida (erstwhile Jaypee Hospital) is nearly complete. Commissioning of brownfield capacities at Max Mohali, Nanavati-Max and Max Smart is underway and operating leverage from the same will start reflecting in the financial and operating metrics soon. On-streaming of brownfield capacities and strong underlying demand in our micro markets will further bolster our leadership position in the delivery of quality healthcare to our patients. Max Healthcare Institute (Max Healthcare) is one of India's largest healthcare organizations. The company operates 20 healthcare facilities (nearly 5,200 beds) with a significant presence in North India. In addition to the hospitals, Max Healthcare operates homecare and pathology businesses under brand names Max@Home and Max Lab, respectively. The scrip had added 0.26% to end at Rs 1101.40 on the BSE on Friday. Powered by Capital Market - Live

Sun TV Network Ltd, Cholamandalam Financial Holdings Ltd, Adani Power Ltd and Sammaan Capital Ltd are among the other losers in the BSE's 'A' group today, 03 October 2025.Max Healthcare Institute Ltd tumbled 4.38% to Rs 1063.85 at 14:47 IST.The stock was the biggest loser in the BSE's 'A' group.On the BSE, 95187 shares were traded on the counter so far as against the average daily volumes of 79922 shares in the past one month.Sun TV Network Ltd crashed 4.26% to Rs 576.45. The stock was the second biggest loser in 'A' group.On the BSE, 1.11 lakh shares were traded on the counter so far as against the average daily volumes of 35875 shares in the past one month.Cholamandalam Financial Holdings Ltd lost 3.55% to Rs 1840.2. The stock was the third biggest loser in 'A' group.On the BSE, 12692 shares were traded on the counter so far as against the average daily volumes of 6930 shares in the past one month.Adani Power Ltd shed 2.98% to Rs 147.9. The stock was the fourth biggest loser in 'A' group.On the BSE, 88.67 lakh shares were traded on the counter so far as against the average daily volumes of 52.83 lakh shares in the past one month.Sammaan Capital Ltd corrected 2.89% to Rs 164.65. The stock was the fifth biggest loser in 'A' group.On the BSE, 41.76 lakh shares were traded on the counter so far as against the average daily volumes of 14.65 lakh shares in the past one month.Powered by Capital Market - Live

Net profit of Max Healthcare Institute rose 30.35% to Rs 307.97 crore in the quarter ended June 2025 as against Rs 236.27 crore during the previous quarter ended June 2024. Sales rose 31.41% to Rs 2027.57 crore in the quarter ended June 2025 as against Rs 1542.95 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales2027.571542.95 31 OPM %25.7925.11 - PBDT504.57398.21 27 PBT400.43321.31 25 NP307.97236.27 30 Powered by Capital Market - Live

The Board of Max Healthcare Institute at its meeting held on 13 August 2025 has approved to enter into an agreement to lease with Goyal Agrim Infra Realty LLP for setting up ~130 bedded hospital at Dehradun, Uttarakhand on a built-to-suit basis. Goyal Agrim will construct, develop and furnish the hospital building as per the Company's specifications and requirements at its own costs and expenses. The responsibility for construction of hospital including obtaining of approvals like occupancy certificate is with Goyal Agrim. The initial lease term will be 29 years and shall further be renewed for 29 years. Powered by Capital Market - Live

Max Healthcare Institute has allotted 80,000 equity shares under ESOS on 12 August 2025. With this allotment, the paid up equity share capital has increased to 972,22,68,430 equity shares of Rs 10 each. Powered by Capital Market - Live

Max Healthcare Institute will hold a meeting of the Board of Directors of the Company on 13 August 2025.Powered by Capital Market - Live

Max Healthcare Institute announced that the 24th Annual General Meeting(AGM) of the company will be held on 30 July 2025.Powered by Capital Market - Live

Net profit of Max Healthcare Institute rose 26.82% to Rs 319.00 crore in the quarter ended March 2025 as against Rs 251.54 crore during the previous quarter ended March 2024. Sales rose 34.21% to Rs 1909.74 crore in the quarter ended March 2025 as against Rs 1422.90 crore during the previous quarter ended March 2024. For the full year,net profit rose 1.72% to Rs 1075.88 crore in the year ended March 2025 as against Rs 1057.64 crore during the previous year ended March 2024. Sales rose 30.01% to Rs 7028.46 crore in the year ended March 2025 as against Rs 5406.02 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales1909.741422.90 34 7028.465406.02 30 OPM %26.7926.81 -26.3027.60 - PBDT503.33406.05 24 1839.421610.30 14 PBT402.50335.73 20 1480.001365.32 8 NP319.00251.54 27 1075.881057.64 2 Powered by Capital Market - Live

Max Healthcare Institute announced that the Board of Directors of the Company at its meeting held on 20 May 2025, inter alia, have recommended the final dividend of Rs 1.5 per equity Share (i.e. 15%) , subject to the approval of the shareholders.Powered by Capital Market - Live